Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory ...
The new 10-year co-branded card deal with Citi, effective in 2026, is expected to boost cash remuneration by ~10% annually, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback